Zusammenfassung
Das Ziel bei der Therapie der Femurkopfnekrose des Erwachsenen ist es, den Hüftkopf zu erhalten und einen künstlichen Gelenkersatz zu vermeiden. Die Core-Dekompression bietet neben der intraossären Druckentlastung zusätzlich die Möglichkeit, bioaktive Materialien, Substanzen und Zellen in den Bohrkanal einzubringen. Hierzu zählen vaskularisierte und nichtvaskularisierte Knochentransplantate, allogene und synthetische Knochenersatzmaterialien, osteogen und angiogen wirkende Wachstumsfaktoren sowie unterschiedliche Vorläuferzellen. Insbesondere der Einsatz neuer zellbasierter Verfahren hat ein großes therapeutisches Potenzial und könnte zukünftig einen entscheidenden Fortschritt bei der Behandlung der Femurkopfnekrose bedeuten. In diesem Beitrag werden die bisherigen klinischen Erfahrungen der zellbasierten Strategien zur Therapie der Femurkopfnekrose des Erwachsenen zusammenfasst und ein eigener neu entwickelter Therapieansatz unter der Verwendung von Knochenmarkstammzellen (TRCs: „tissue repair cells“) in Kombination mit einer β-TCP-Matrix vorgestellt.
Abstract
The goal of the therapy for necrosis of the femoral head in adults is the preservation of the femoral head and, therefore, avoidance of total joint replacement. Core decompression is known to reduce the intraosseous pressure and additionally provides the opportunity to introduce bioactive materials, substances and cells into the core tract. These include vascularized and non-vascularized bone grafts, allogenic and synthetic bone substitutes, osteogenic and angiogenic growth factors, as well as different progenitor cells. In particular, the use of cell-based strategies has great therapeutic potential and could play an important role in the treatment of femoral head necrosis in adults in the future. In this article, we summarize the existing clinical experience of current cell-based strategies for the treatment of femoral head necrosis in adults, and present a therapeutic approach using bone marrow stem cells (TRCs: tissue repair cells). in combination with a β-TCP matrix.
Literatur
Aaron RK, Ciombor DM, Lord CF (1997) Core decompression augmented with human decalcified bone matrix for osteonecrosis of the femoral head. In: Urbaniak JR, Jones JP (eds) Osteonecrosis: Etiology, Diagnosis and Treatment. Rosemont Il. Am Acad Orthop Surg pp 301–307
Cancedda R, Bianchi G, Derubeis A, Quarto R (2003) Cell therapy for bone disease: a review of current status. Stem Cells 21: 610–619
Ficat F, Arlet J (1971) Biopsy-forage in the treatment of primary femoro-capital osteonecrosis. Presse Med 79: 581
Gangji V, Hauzeur JP, Matos C et al. (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86: 1153–1160
Gangji V, Hauzeur JP (2005) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am (Suppl 1) 87: 106–112
Gangji V, Toungouz M, Hauzeur JP (2005) Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 5: 437–442
Hauzeur JP, Orloff S, Taverne-Verbanck J, Pasteels JL (1986) Diagnosis of aseptic osteonecrosis of the femoral head by percutaneous transtrochanterian needle biopsy. Clin Rheumatol 5: 346–358
Hauzeur JP, Pasteels JL, Orloff S (1987) Bilateral non-traumatic aseptic osteonecrosis in the femoral head. An experimental study of incidence. J Bone Joint Surg Am 69: 1221–1225
Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 405: 14–23
Hernigou P, Manicom O, Poignard A et al. (2004) Core decompression with marrow stem cells. Operative Tech Orthop 14: 68–74
Hernigou P, Poignard A, Manicom O et al. (2005) The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 78: 896–902
Hungerford DS (1981) Pathogenetic considerations in ischemic necrosis of bone. Can J Surg 24: 583–587
Iwata H, Torii S, Hasegawa Y et al. (1993) Indications and results of vascularized pedicle iliac bone graft in avascular necrosis of the femoral head. Clin Orthop 295: 281–288
Kawate K, Yajima H, Ohgushi H et al. (2006) Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30: 960–962
Keizer SB, Kock NB, Dijkstra PD et al. (2006) Treatment of avascular necrosis of the hip by a non-vascularised cortical graft. J Bone Joint Surg Br 88: 460–466
Kiaer T, Pedersen NW, Kristensen KD, Starklint H (1990) Intra-osseous pressure and oxygen tension in avascular necrosis and osteoarthritis of the hip. J Bone Joint Surg Br 72: 1023–1030
Lieberman JR, Berry DJ, Mont MA et al. (2002) Osteonecrosis of the hip: management in the 21st century. J Bone Joint Surg 84: 834–853
Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop 429: 139–144
Owen ME, Cave J, Joyner CJ (1987) Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 87: 731–738
Plenk H Jr, Hofmann S, Breitenseher M, Urban M (2000) Pathomorphological aspects and repair mechanisms of femur head necrosis. Orthopäde 29: 389–402
Steinberg ME, Hayken GD, Steinberg DR (1995) A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 77: 34–41
Steinberg ME, Larcom PG, Strafford B et al. (2001) Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop 386: 71–78
Urbaniak JR, Coogan PG, Gunneson EB, Nunley JA (1995) Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am 77: 681–694
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nöth, U., Reichert, J., Reppenhagen, S. et al. Zellbasierte Therapie der Femurkopfnekrose. Orthopäde 36, 466–471 (2007). https://doi.org/10.1007/s00132-007-1087-2
Issue Date:
DOI: https://doi.org/10.1007/s00132-007-1087-2